Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Murugappan MN"'
Autor:
Horodniceanu EG; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: erica.horodniceanu@fda.hhs.gov., Datla T; ORISE Fellow, Center for Drug Evaluation and Research, Office of Oncologic Diseases, US Food and Drug Administration, Silver Spring, MD, USA., Murugappan MN; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA., Kanapuru B; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Amiri-Kordestani L; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Larkins E; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Kluetz P; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA., Bhatnagar V; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Oct 09. Date of Electronic Publication: 2024 Oct 09.
Autor:
Murugappan MN; ORISE Fellow, Office of Oncologic Diseases, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (U.S. FDA), Silver Spring, MD, USA; Department of Pharmaceutical Care and Health Systems, University of Minnesota - College of Pharmacy, Minneapolis, MN, USA. Electronic address: Meena.Murugappan@fda.hhs.gov., King-Kallimanis BL; LUNGevity Foundation, Chicago, IL, USA., Bhatnagar V; Oncology Center for Excellence U.S. Food and Drug Administration (U.S. FDA), Silver Spring, MD, USA., Kanapuru B; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (U.S. FDA), Silver Spring, MD, USA., Farley JF; Department of Pharmaceutical Care and Health Systems, University of Minnesota - College of Pharmacy, Minneapolis, MN, USA., Seifert RD; Department of Pharmaceutical Care and Health Systems, University of Minnesota - College of Pharmacy, Minneapolis, MN, USA., Stenehjem DD; Department of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota - College of Pharmacy, Minneapolis, MN, USA., Chen TY; ORISE Fellow, Office of Oncologic Diseases, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (U.S. FDA), Silver Spring, MD, USA., Horodniceanu EG; Oncology Center for Excellence U.S. Food and Drug Administration (U.S. FDA), Silver Spring, MD, USA., Kluetz PG; Oncology Center for Excellence U.S. Food and Drug Administration (U.S. FDA), Silver Spring, MD, USA.
Publikováno v:
Journal of geriatric oncology [J Geriatr Oncol] 2024 Mar; Vol. 15 (2), pp. 101681. Date of Electronic Publication: 2023 Dec 16.
Autor:
Aby ES; Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, Minnesota, USA., Shen TH; Department of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota, College of Pharmacy, Minneapolis, Minnesota, USA., Murugappan MN; Department of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota, College of Pharmacy, Minneapolis, Minnesota, USA., Stenehjem DD; Department of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota, College of Pharmacy, Minneapolis, Minnesota, USA., Leventhal TM; Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, Minnesota, USA.
Publikováno v:
Hepatology communications [Hepatol Commun] 2023 Aug 03; Vol. 7 (8). Date of Electronic Publication: 2023 Aug 03 (Print Publication: 2023).
Autor:
Murugappan MN; Office of Oncologic Diseases, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (U.S. FDA), Silver Spring, MD, USA. Meena.Murugappan@fda.hhs.gov.; Department of Pharmaceutical Care and Health Systems, University of Minnesota - College of Pharmacy, Minneapolis, MN, USA. Meena.Murugappan@fda.hhs.gov.; Oncology Center of Excellence, Food and Drug Administration, Building 22, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA. Meena.Murugappan@fda.hhs.gov., King-Kallimanis BL; LUNGevity Foundation, Chicago, IL, USA., Bhatnagar V; Oncology Center for Excellence (U.S. FDA), Silver Spring, MD, USA., Kanapuru B; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (U.S. FDA), Silver Spring, MD, USA., Farley JF; Department of Pharmaceutical Care and Health Systems, University of Minnesota - College of Pharmacy, Minneapolis, MN, USA., Seifert RD; Department of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota - College of Pharmacy, Minneapolis, MN, USA., Stenehjem DD; Department of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota - College of Pharmacy, Minneapolis, MN, USA., Chen TY; Office of Oncologic Diseases, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (U.S. FDA), Silver Spring, MD, USA., Horodniceanu EG; Oncology Center for Excellence (U.S. FDA), Silver Spring, MD, USA., Kluetz PG; Oncology Center for Excellence (U.S. FDA), Silver Spring, MD, USA.
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2023 Aug; Vol. 32 (8), pp. 2281-2292. Date of Electronic Publication: 2023 Mar 20.
Autor:
Murugappan MN; University of Minnesota - College of Pharmacy, Minneapolis, USA., Westberg SM; University of Minnesota - College of Pharmacy, Minneapolis, USA., Contag S; M-Health Fairview, Minneapolis, MN, USA.; University of Minnesota Medical School, Minneapolis, USA., Melnik TE; M-Health Fairview, Minneapolis, MN, USA.; University of Minnesota Medical School, Minneapolis, USA., Kumar A; University of Minnesota - College of Pharmacy, Minneapolis, USA., Rajpurohit A; University of Minnesota - College of Pharmacy, Minneapolis, USA., Thorsness K; Hennepin Healthcare, Minneapolis, MN, USA., Farley JF; University of Minnesota - College of Pharmacy, Minneapolis, USA.
Publikováno v:
Journal of attention disorders [J Atten Disord] 2022 Aug; Vol. 26 (10), pp. 1347-1356. Date of Electronic Publication: 2022 Jan 20.
Autor:
Murugappan MN; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., King-Kallimanis BL; LUNGevity Foundation, Chicago, Illinois., Mangir C; Association of Community Cancer Centers, Rockville, Maryland., Howie L; Pardee Hospital, University of North Carolina Health, Hendersonville, North Carolina., Bhatnagar V; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland., Beaver JA; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland., Basch EM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Henson SR; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Kluetz PG; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Cancer [Cancer] 2022 Jun 15; Vol. 128 (12), pp. 2386-2387. Date of Electronic Publication: 2022 Apr 07.
Publikováno v:
Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2022 May-Jun; Vol. 62 (3), pp. 783-790. Date of Electronic Publication: 2021 Dec 30.
Autor:
Murugappan MN; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., King-Kallimanis BL; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland., Mangir C; Association of Community Cancer Centers, Rockville, Maryland., Howie L; Pardee Hospital, University of North Carolina Health, Hendersonville, North Carolina., Bhatnagar V; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland., Beaver JA; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland., Basch EM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Henson SR; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Kluetz PG; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Cancer [Cancer] 2022 Feb 15; Vol. 128 (4), pp. 808-818. Date of Electronic Publication: 2021 Oct 11.
Autor:
Murugappan MN; Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., King-Kallimanis BL; Oncology Center for Excellence, US Food and Drug Administration, Silver Spring, MD, USA., Reaman GH; Oncology Center for Excellence, US Food and Drug Administration, Silver Spring, MD, USA., Bhatnagar V; Oncology Center for Excellence, US Food and Drug Administration, Silver Spring, MD, USA., Horodniceanu EG; Oncology Center for Excellence, US Food and Drug Administration, Silver Spring, MD, USA., Bouchkouj N; Oncology Center for Excellence, US Food and Drug Administration, Silver Spring, MD, USA., Kluetz PG; Oncology Center for Excellence, US Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2022 Jan 11; Vol. 114 (1), pp. 12-19.
Publikováno v:
Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2020 Sep - Oct; Vol. 60 (5S), pp. S54-S63.